Evaluation of the Antifungal and Antiproliferative Properties of the Lichen <i>Roccella tinctoria</i> DC. Extracts and Main Components
In this work, phytochemical analysis on different extracts of <i>Roccella tinctoria</i> DC. was reported using different techniques with respect to the past. Twenty volatile and three non-volatile compounds were identified, some of which were found in this species for the first time. The...
Saved in:
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | In this work, phytochemical analysis on different extracts of <i>Roccella tinctoria</i> DC. was reported using different techniques with respect to the past. Twenty volatile and three non-volatile compounds were identified, some of which were found in this species for the first time. The methanolic extracts and their non-volatile components were then evaluated for their antitumor effects in cancerous A549 and Mz-ChA-1 cells and for their tolerability in non-cancerous BEAS-2B and H69 cells, showing IC<sub>50</sub> values from 94.6 µg/mL to 416.4 µg/mL, in general. The same extracts and compounds were also tested for their antifungal effects in <i>Candida albicans,</i> with only compound <b>2</b> being active, with an MIC<sub>50</sub> value of 87 µg/mL. In addition, they were tested for their anti-<i>Candida</i> adhesion activity, anti-<i>Candida</i> biofilm formation, and anti-<i>Candida</i> mature biofilm inhibition, with efficacy percentages generally above 50% but not for all of them. Lastly, the DF3 extract and compounds <b>1</b>-<b>2</b> were tested in vivo according to the <i>Galleria mellonella</i> survival assay, showing positive mortality rates above 50% at different concentrations. All these biological assays were conducted on this species for the first time. Comparisons with other lichens and compounds were also presented and discussed. |
---|---|
Item Description: | 10.3390/pharmaceutics16030331 1999-4923 |